News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
María José Juan-Fita: It’s probably time to open the field of tumour microenvironment research and test new therapies in prostate cancer as well
Photo of María José Juan-Fita taken from: educa-med.online/educa-news
Mar 7, 2024, 01:32

María José Juan-Fita: It’s probably time to open the field of tumour microenvironment research and test new therapies in prostate cancer as well

María José Juan-Fita, Medical Oncologist at the Valencian Institute of Oncology Foundation, shared the following post by Emmanuel Antonarakis, Professor of Medicine, University of Minnesota, on X, adding the following:

“It’s probably time to open the field of tumour microenvironment research and test new therapies in prostate cancer as well.”

María José Juan-Fita: It’s probably time to open the field of tumour microenvironment research and test new therapies in prostate cancer as well María José Juan-Fita: It’s probably time to open the field of tumour microenvironment research and test new therapies in prostate cancer as well María José Juan-Fita: It’s probably time to open the field of tumour microenvironment research and test new therapies in prostate cancer as well María José Juan-Fita: It’s probably time to open the field of tumour microenvironment research and test new therapies in prostate cancer as well

“Congrats Nicholas Zorko for your new paper characterizing NK cell landscape in PCa, and the associated clinical and molecular features. Now it’s time for some NK-directed therapeutics in PCa. Thanks to PCF Science for funding this brilliant young investigator.”

Source: María José Juan-Fita/X and Emmanuel Antonarakis/X

cancer María José Juan-Fita Nicholas Zorko NK cell OncoDaily Oncology PCF Science Research
Special Coverage
Blog
Apr 22, 2025, 19:24
Esra Bilir: Great pleasure and honor to interview Nadeem Abu-Rustum
Blog
Apr 22, 2025, 18:41
Nurses Community of Practice and GPON Spotlight Advocacy in Precision Oncology - FT3
Blog
Apr 22, 2025, 18:28
Vidith Phillips: AI x Oncology - Research Highlights Shaping Cancer Care in 2025
Blog
Apr 22, 2025, 18:02
Afreen Shariff: Fatigue is not just a side effect - it’s a serious complex, and often overlooked challenge in cancer care
Blog
Apr 22, 2025, 17:31
Vivek Subbiah: It's moments like these that remind me why I do what I do
Positive
Apr 22, 2025, 17:21
Foundation S marks 20 years of impact through My Child Matters - Childhood Cancer International
Blog
Apr 22, 2025, 17:11
Lisa A. Lacasse: We’re able to elevate the patient voice in the fight against cancer at every level of government
Blog
Apr 22, 2025, 17:05
Paul Ekert presents ZERO program at St. Jude Symposium - Children's Cancer Institute
Blog
Apr 22, 2025, 16:58
Wafik S. El-Deiry: Best Practices for Sponsored Research event
Opinion
Apr 22, 2025, 16:42
Nathan Pennell: The Medical community needs to oppose the Department of Justice's threats to journal independence
Blog
Apr 22, 2025, 16:28
Ruben Mesa: Celebrating the extraordinary 27 year tenure of Bayard Powell as the Chief of Hematology and Medical Oncology
Career
Apr 22, 2025, 16:21
Five MD Anderson researchers were honored with 2025 AACR Scientific Achievement Awards